Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The copper-associated protein STEAP2 correlated with glioma prognosis and immune infiltration. | Front Cell Neurosci | 2022 | 36060273 | PubTator, text mining | PubMed |
| Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer. | Front Immunol | 2022 | 36059516 | PubTator, text mining | PubMed |
| The function and regulatory mechanism of RNA-binding proteins in breast cancer and their future clinical treatment prospects. | Front Oncol | 2022 | 36052258 | PubTator, text mining | PubMed |
| Longitudinal neurological analysis of moderate and severe pediatric cerebral visual impairment. | Front Hum Neurosci | 2022 | 36051970 | PubTator, text mining | PubMed |
| Establishment and Characterization of Carboplatin-Resistant Retinoblastoma Cell Lines. | Mol Cells | 2022 | 36047446 | PubTator, text mining | PubMed |
| A novel defined cuproptosis-related gene signature for predicting the prognosis of lung adenocarcinoma. | Front Genet | 2022 | 36046242 | PubTator, text mining | PubMed |
| Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas. | Front Immunol | 2022 | 36045691 | PubTator, text mining | PubMed |
| Structural basis of ion uptake in copper-transporting P1B-type ATPases. | Nat Commun | 2022 | 36045128 | PubTator, text mining | PubMed |
| Addition of Gallic Acid Overcomes Resistance to Cisplatin in Ovarian Cancer Cell Lines. | Asian Pac J Cancer Prev | 2022 | 36037120 | PubTator, text mining | PubMed |
| Expression profiles of exosomal tRNA-derived fragments and their biological functions in lipomas. | Front Cell Dev Biol | 2022 | 36035989 | PubTator, text mining | PubMed |
| Development and validation of cuproptosis-related gene signature in the prognostic prediction of liver cancer. | Front Oncol | 2022 | 36033443 | PubTator, text mining | PubMed |
| A mixed-methods, cross-sectional study of perceived stigma among Ugandans with epilepsy. | Afr Health Sci | 2022 | 36032474 | PubTator, text mining | PubMed |
| The current state of the art and future trends in RAS-targeted cancer therapies. | Nat Rev Clin Oncol | 2022 | 36028717 | PubTator, text mining | PubMed |
| Augmented Therapeutic Potential of EC-Synthetic Retinoids in Caco-2 Cancer Cells Using an In Vitro Approach. | Int J Mol Sci | 2022 | 36012706 | PubTator, text mining | PubMed |
| Identification of a Novel Cuproptosis-Related Gene Signature for Prognostic Implication in Head and Neck Squamous Carcinomas. | Cancers (Basel) | 2022 | 36010978 | PubTator, text mining | PubMed |
| Low Copper Diet-A Therapeutic Option for Wilson Disease? | Children (Basel) | 2022 | 36010023 | PubTator, text mining | PubMed |
| Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids. | Nat Commun | 2022 | 36008377 | PubTator, text mining | PubMed |
| Cuproptosis predicts the risk and clinical outcomes of lung adenocarcinoma. | Front Oncol | 2022 | 36003780 | PubTator, text mining | PubMed |
| High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases. | BMC Bioinformatics | 2022 | 35996075 | PubTator, text mining | PubMed |
| Transcriptional and genetic alterations of cuproptosis-related genes correlated to malignancy and immune-infiltrate of esophageal carcinoma. | Cell Death Discov | 2022 | 35995782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=39